QuidelOrtho (QDEL) - 2023 Q1 - Earnings Call Transcript

In terms of capital deployment in the first quarter, we paid down $52 million of debt working towards the$206 million minimum payments in 2023. And while we did not buy back any shares in the quarter, we intend to maintain a balanced and opportunistic approach to share repurchases while also continuing to prioritize our debt paydown going forward. Notably, following the end of the quarter, we made our final $40 million payment to Abbott for the$680 million purchase of the Alere cardiometabolic assets. We ...